Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W NORDEN

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1980
Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combinationC W Norden, E Keleti
Chemotherapy|January 1, 1987
In vitro activity of BMY-28142, a new cephalosporinC W Norden, K Neiderriter
The Journal of Infectious Diseases|January 1, 1980
Experimental osteomyelitis caused by Pseudomonas aeruginosaC W Norden, E Keleti
The Journal of Infectious Diseases|February 1, 1983
Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampinC W Norden, M Shaffer
The Journal of Infectious Diseases|February 1, 1985
Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosaC W Norden, E Shinners
Chemotherapy|January 1, 1984
Treatment of experimental chronic osteomyelitis caused by Morganella morganii with mezlocillin and cloxacillinC W Norden, M Shaffer
The Journal of Antimicrobial Chemotherapy|April 1, 1983
In-vitro synergism between mezlocillin and isoxazolyl penicillins against beta-lactamase-producing Gram-negative organismsC W Norden, M Shaffer
Chemotherapy|January 1, 1988
In vitro activity of BMY-28100, a new oral cephalosporinC W Norden, K Niederriter
The Journal of Infectious Diseases|January 1, 1990
Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactamC W Norden, A Budinsky
Antimicrobial Agents and Chemotherapy|January 1, 1982
Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosaC W Norden, M A Shaffer
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|April 1, 1980
Treatment of experimental staphylococcal osteomyelitis with rifampin and trimethoprim, alone and in combinationC W Norden, E Keleti
Chemotherapy|January 1, 1987
In vitro activity of BMY-28142, a new cephalosporinC W Norden, K Neiderriter
The Journal of Infectious Diseases|January 1, 1980
Experimental osteomyelitis caused by Pseudomonas aeruginosaC W Norden, E Keleti
The Journal of Infectious Diseases|February 1, 1983
Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampinC W Norden, M Shaffer
The Journal of Infectious Diseases|February 1, 1985
Ciprofloxacin as therapy for experimental osteomyelitis caused by Pseudomonas aeruginosaC W Norden, E Shinners
Chemotherapy|January 1, 1984
Treatment of experimental chronic osteomyelitis caused by Morganella morganii with mezlocillin and cloxacillinC W Norden, M Shaffer
The Journal of Antimicrobial Chemotherapy|April 1, 1983
In-vitro synergism between mezlocillin and isoxazolyl penicillins against beta-lactamase-producing Gram-negative organismsC W Norden, M Shaffer
Chemotherapy|January 1, 1988
In vitro activity of BMY-28100, a new oral cephalosporinC W Norden, K Niederriter
The Journal of Infectious Diseases|January 1, 1990
Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactamC W Norden, A Budinsky
Antimicrobial Agents and Chemotherapy|January 1, 1982
Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosaC W Norden, M A Shaffer
Pageof 6